NetworkNewsBreaks – FinCanna Capital Corp. (CSE:
Post# of 30

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced the appointment of Ms. Rosy Mondin, a leading advocate for the legalization of adult use cannabis in Canada, to its Board of Advisors. Mondin co-founded Soma Labs Scientific in 2014, which amalgamated to form Quadron Cannatech Corporation in 2016. Mondin serves as CEO and director Quadron Cannatech Corporation, making her the first woman to hold the role of CEO in a publicly traded company in the cannabis sector. “We are honored to have a woman with Rosy’s in-depth industry knowledge join our Board of Advisors. Her addition serves to further strengthen our team of well-respected industry thought leaders,” FinCanna Capital president and CEO Andriyko Herchak stated in the news release. “Rosy’s credibility within government, advocacy, education, and business circles has earned her a solid reputation as an entrepreneurial leader, special advisor, and legislative authority in the cannabis space. We look forward to her contributions to FinCanna as our investee companies move towards commercialization and we expand our royalty portfolio.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

